Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ORMP

Oramed Pharmaceuticals (ORMP)

Oramed Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ORMP
DateTimeSourceHeadlineSymbolCompany
26/06/202423:05PR Newswire (US)Oramed Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
26/06/202423:00PR Newswire (US)Oramed Pharmaceuticals Inc. Announces the Buy-Back of its Common StockNASDAQ:ORMPOramed Pharmaceuticals Inc
20/06/202421:32Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ORMPOramed Pharmaceuticals Inc
20/06/202421:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ORMPOramed Pharmaceuticals Inc
11/06/202407:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
11/06/202407:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
10/05/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORMPOramed Pharmaceuticals Inc
06/05/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
20/03/202400:00GlobeNewswire Inc.Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and InnovationNASDAQ:ORMPOramed Pharmaceuticals Inc
07/03/202409:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORMPOramed Pharmaceuticals Inc
21/02/202400:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
21/02/202400:30PR Newswire (US)Oramed Letter to ShareholdersNASDAQ:ORMPOramed Pharmaceuticals Inc
31/01/202409:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
24/01/202408:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
20/01/202408:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
09/01/202408:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
03/01/202405:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ORMPOramed Pharmaceuticals Inc
22/12/202301:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
19/12/202308:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORMPOramed Pharmaceuticals Inc
10/11/202309:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORMPOramed Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ORMP